![](/img/cover-not-exists.png)
Antibody fragments targeting the tumor marker mesothelin selectively deliver TRAIL therapeutics and cause efficient ovarian cancer cell death
Kuroki, L.M., Tatzel, K., Powell, M.A., Mutch, D.G., Dietz, A.B., Hawkins, W., Spitzer, D.Volume:
137
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2015.01.335
Date:
April, 2015
File:
PDF, 265 KB
english, 2015